SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PHVS

Pharvaris N.V. (NASDAQ:PHVS)

CH · Delayed Price · Currency is USD
Healthcare · Biotechnology
31.54+0.13 (+0.41%)
 
Market cap
$2.20B
Health Score
Analyst consensus
Listed since
Feb 4, 2021
Insider Score
––Not scored
PHVS Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

Financial Health Score
Fair
From PHVS’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars
Profitability—

No revenue reported, so there is no margin to score.

Revenue
$0
Net income
-$171.6M
Net margin
—
Leverage20 / 20

Little or no net debt.

Total debt
$674K
Cash
$318.3M
Debt / equity
0.00
Liquidity20 / 20

Comfortably covers what is due within a year.

Current assets
$326.9M
Current liabilities
$27.4M
Current ratio
11.94
Cash generation3 / 20

Consumes cash and must keep raising it.

Operating cash flow
-$156.0M
Free cash flow
-$156.1M
Dilution & runway0 / 20

Heavy dilution — shareholders are paying for the business.

Shares outstanding
68.1M
Share growth (1y)
24.5%
Cash runway
24 months

Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.

PHVS Income Statement

Fiscal PeriodQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Revenue0.000.000.000.000.000.00
Revenue Growth (YoY)——————
Cost of Revenue0.00106.45 K0.000.000.000.00
Gross Profit0.00-106.45 K0.000.000.000.00
SG&A Expense15.79 M14.24 M13.46 M9.85 M10.77 M11.27 M
R&D Expense35.00 M30.66 M34.14 M29.81 M29.61 M30.91 M
Operating Expenses50.79 M44.89 M47.60 M39.66 M40.37 M-42.19 M
Operating Income-50.79 M-45.00 M-47.60 M-39.66 M-40.37 M42.19 M
Pretax Income-47.24 M-39.57 M-45.08 M-37.32 M-45.28 M-46.04 M
Tax Provision602.20 K277.60 K1.66 M-181.47 K202.78 K302.67 K
Net Income-47.84 M-39.85 M-46.74 M-37.14 M-45.48 M-46.34 M
EPS (Basic)-0.70-0.61-0.79-0.60-0.83-0.85
EPS (Diluted)-0.70-0.61-0.79-0.60-0.83-0.85
Shares Outstanding68.07 M65.31 M59.16 M62.26 M54.69 M54.52 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.